25 May 2013
Keywords: new, trial, results, pharming, rhucin, confirm, ready
Article | 23 June 2008
Dutch biotechnology firm Pharming has released positive results for a new US trial on its recombinant human C1 inhibitor Rhucin ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.